Literature DB >> 24800026

Cytokine Gene Polymorphisms in Childhood Dilated Cardiomyopathy: Interferon- gamma, Tumor Necrosis Factor-alpha and Transforming Growth Factor - beta 1 Genes Are Associated with the Disease in Turkish Patients.

Sibel Oguzkan Balci1, Nilgun Col-Araz2, Osman Baspinar3, Tugce Sever1, Ayse Balat4, Sacide Pehlivan1.   

Abstract

Entities:  

Keywords:  Cytokines; Dilated cardiomyopathy; Gene Polymorphism

Year:  2013        PMID: 24800026      PMCID: PMC4006515     

Source DB:  PubMed          Journal:  Iran J Pediatr        ISSN: 2008-2142            Impact factor:   0.364


× No keyword cloud information.
Dilated cardiomyopathy (DCM) is a cardiac muscle disease with reduced left ventricular systolic function[. Myocardial inflammation is the most common mechanism in the pathogenesis of cardiomyopathy in which cytokines may play an important role[. The objective of this study was to investigate the associations between tumor necrosis factor-alpha (TNF-α, -308), transforming growth factor-beta 1 (TGF-β1, +10, +25), interleukin-10 (IL-10, -1082, -819, and -592), interleukin-6 (IL-6, -174), interferon-gamma (IFN-γ, +874) gene polymorphisms and DCM. Sixteen children with DCM (3 months-13 years) and 21 healthy controls were tested for the cytokine genes with polymerase chain reaction-sequence-specific primers (PCR-SSP). In our results, TNF-α (-308) A allele was higher in DCM (P=0.03). The frequency of TNF-α (-308) GG genotype (low expression) was significantly decreased in DCM (P=0.02). The children with DCM had significantly higher frequencies of IFN-γ (+874) TT genotype (high expression) and allele T while TA genotype (intermediate expression) was lower in patients (P=0.003, P=0.01 and P=0.04, respectively). Haplotype analyses showed that TT/GG and TC/GG ha plotypes of TGF-β1 (high expression) were significantly decreased while TC/GC, CC/GG and TT/GC (intermediate expression) haplotypes were increased (P=0.01 and P=0.04, respectively). There was no association between IL-6 and IL-10 genotypes/haplotypes and DCM (P>0.05). TNF-α is a strong proinflammatory and immunomodulatory cytokine that intervenes inflammatory diseases and is produced by activated macrophages[. Frequency of TNF-α allele A was found high in DCM[. TNF-α allele A (-308) was found over-expressed in patients with end-stage non-ischemic myocardial dysfunction[. Tired et al did not find any association between TNF-α (-308) polymorphism and DCM[. In our study, allele A of TNF-α (-308) gene was found susceptible to DCM, while GG genotype of TNF-α (-308) showed a protective effect against the disease. The production or activities of several cytokines are modulated by IFN-γ[. The AA homozygosity of IFN-γ (+874) T/A polymorphism was associated with poor prognosis in idiopathic DCM in older patients[. IFN-γ protected against the development of severe chronic myocarditis, pericarditis, and DCM after Coxackievirus B3 infection by reducing mast cell degranulation, and the profibrotic cytokines (IL-4, IL-1β, TGF-β1) in the heart[. In our study, the high expression of IFN-γ was found susceptible to DCM. We hypothesized that IFN-γ might play a possible role in the immuno-inflammatory process of childhood DCM, although it is not clear whether these act to preserve or protect against further inflammatory injury. IL-6 is one of the proinflammatory cytokines with many systemic effects, including cardiovascular system[. The GG and GC genotypes of IL-6 (-174) are associated with increased levels of IL-6, while CC with decreased expression[. IL-6 levels were significantly associated with all outcomes of heart disease in adults[. IL-6 (-174) polymorphism was associated with LVESD and LVEDD in DCM[. Although allele C was higher in our patient group, there was borderline statistical significance between the groups (P=0.0590). IL-10 is a regulatory cytokine which inhibits the production of IFN-γ and TNF-α and antagonizes the proinflammatory cytokine response[. The diagnosis of DCM has been associated with a reduction in IL-10 plasma levels, indicating its protective role in cytokine activation[. However, recent studies have suggested that IL-10 polymorphisms are not associated with DCM[, in agreement with our results. TGF-β1 is an anti-inflammatory cytokine that might play a major role in the immune modulation of heart function[. TGF-β1 expression is increased in the myocardium of patients with DCM[. TGF-β1 polymorphisms were correlated with better exercise capacity, and heart failure symptoms[. Tiret et al found no relationship between TGF-β1 gene polymorphism and DCM[. This study indicates that the high expression of TGF-β1 had a protective effect against the DCM, while intermediate expression had susceptibility to the disease. Fairweather et al reported that IFN-γ protected against the development of DCM after infection by reducing profibrotic cytokines like TGF-β1[. We conclude that the increase in the expression of IFN-γ and TNF-α genes may be associated with the etiopathogenesis of DCM; however, the increase in the expression of TGF-β1 gene may play a protective role against the development of this disease.
  14 in total

1.  Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study.

Authors:  L Tiret; C Mallet; O Poirier; V Nicaud; A Millaire; J B Bouhour; G Roizès; M Desnos; R Dorent; K Schwartz; F Cambien; M Komajda
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

2.  Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Stamatis Adamopoulos; Fotis Kolokathis; Angeliki Gkouziouta; Panagiota Georgiadou; Antigoni Chaidaroglou; George K Karavolias; Dimitrios Degiannis; Vassilis Voudris; Dimitrios Th Kremastinos
Journal:  Cytokine       Date:  2011-02-01       Impact factor: 3.861

Review 3.  Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy.

Authors:  Lou Vadlamani; Srinivas Iyengar
Journal:  Congest Heart Fail       Date:  2004 Nov-Dec

4.  Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy.

Authors:  M Ito; H Takahashi; K Fuse; S Hirono; T Washizuka; K Kato; F Yamazaki; K Inano; T Furukawa; M Komada; Y Aizawa
Journal:  Jpn Heart J       Date:  2000-03

5.  Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients.

Authors:  Seyedhossein Aharinejad; Katharina Krenn; Patrick Paulus; Romana Schäfer; Andreas Zuckermann; Michael Grimm; Dietmar Abraham
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

6.  Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?

Authors:  C G Densem; I V Hutchinson; N Yonan; N H Brooks
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

7.  The epidemiology of childhood cardiomyopathy in Australia.

Authors:  Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Michael Cheung; Lynette C Wilkinson; Andrew M Davis; Stephen G Kahler; C W Chow; James L Wilkinson; Robert G Weintraub
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 10.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

View more
  2 in total

1.  Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Yuting Cheng; Baiquan An; Man Jiang; Yongning Xin; Shiying Xuan
Journal:  Hepat Mon       Date:  2015-03-31       Impact factor: 0.660

Review 2.  Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case-control studies.

Authors:  Yongdong Zhang; Yanhong Cao; Linlin Xin; Ningning Gao; Bingshuang Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.